[go: up one dir, main page]

SI2230932T1 - Oplaščeni farmacevtski ali nutracevtski pripravek s povečanim sproščanjem aktivne učinkovine v črevesu - Google Patents

Oplaščeni farmacevtski ali nutracevtski pripravek s povečanim sproščanjem aktivne učinkovine v črevesu

Info

Publication number
SI2230932T1
SI2230932T1 SI200831827A SI200831827A SI2230932T1 SI 2230932 T1 SI2230932 T1 SI 2230932T1 SI 200831827 A SI200831827 A SI 200831827A SI 200831827 A SI200831827 A SI 200831827A SI 2230932 T1 SI2230932 T1 SI 2230932T1
Authority
SI
Slovenia
Prior art keywords
colon
active substance
substance release
coated pharmaceutical
enhanced active
Prior art date
Application number
SI200831827A
Other languages
English (en)
Inventor
Hema Ravishankar
Shradda Bodinge
Hans-Ulrich Petereit
Original Assignee
Evonik Roehm Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Evonik Roehm Gmbh filed Critical Evonik Roehm Gmbh
Publication of SI2230932T1 publication Critical patent/SI2230932T1/sl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23P—SHAPING OR WORKING OF FOODSTUFFS, NOT FULLY COVERED BY A SINGLE OTHER SUBCLASS
    • A23P10/00—Shaping or working of foodstuffs characterised by the products
    • A23P10/30—Encapsulation of particles, e.g. foodstuff additives
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L27/00—Spices; Flavouring agents or condiments; Artificial sweetening agents; Table salts; Dietetic salt substitutes; Preparation or treatment thereof
    • A23L27/70—Fixation, conservation, or encapsulation of flavouring agents
    • A23L27/72—Encapsulation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/60—Salicylic acid; Derivatives thereof
    • A61K31/606—Salicylic acid; Derivatives thereof having amino groups
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
    • A61K9/5078—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings with drug-free core

Landscapes

  • Engineering & Computer Science (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Polymers & Plastics (AREA)
  • Food Science & Technology (AREA)
  • Epidemiology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Nutrition Science (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
SI200831827A 2008-01-10 2008-02-01 Oplaščeni farmacevtski ali nutracevtski pripravek s povečanim sproščanjem aktivne učinkovine v črevesu SI2230932T1 (sl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
IN95CH2008 2008-01-10
PCT/EP2008/051236 WO2009086940A1 (en) 2008-01-10 2008-02-01 Coated pharmaceutical or nutraceutical preparation with enhanced active substance release in the colon
EP08708546.0A EP2230932B1 (en) 2008-01-10 2008-02-01 Coated pharmaceutical or nutraceutical preparation with enhanced active substance release in the colon

Publications (1)

Publication Number Publication Date
SI2230932T1 true SI2230932T1 (sl) 2017-07-31

Family

ID=39798120

Family Applications (1)

Application Number Title Priority Date Filing Date
SI200831827A SI2230932T1 (sl) 2008-01-10 2008-02-01 Oplaščeni farmacevtski ali nutracevtski pripravek s povečanim sproščanjem aktivne učinkovine v črevesu

Country Status (14)

Country Link
US (1) US9237760B2 (sl)
EP (1) EP2230932B1 (sl)
JP (1) JP5409651B2 (sl)
KR (1) KR101500792B1 (sl)
CN (1) CN101877971A (sl)
BR (1) BRPI0822026B8 (sl)
CA (1) CA2711473C (sl)
ES (1) ES2626078T3 (sl)
HU (1) HUE034848T2 (sl)
IL (1) IL205488A (sl)
MX (1) MX2010007577A (sl)
PL (1) PL2230932T3 (sl)
SI (1) SI2230932T1 (sl)
WO (1) WO2009086940A1 (sl)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BRPI0721654B8 (pt) 2007-05-07 2022-07-05 Evonik Roehm Gmbh formas de dosagem sólida compreendendo um revestimento entérico com liberação acelerada do fármaco, seu método de fabricação e uso
US20150164920A1 (en) * 2012-03-30 2015-06-18 Laboratorios Del Dr. Esteve S.A. Controlled release formulation comprising mesalamine
US20140141075A1 (en) 2012-11-21 2014-05-22 Warner Chilcott Company, Llc 5-aminosalicylic acid capsule formulation
US11229600B2 (en) * 2014-09-24 2022-01-25 Vital Beverages Global Inc. Compositions and methods for selective GI tract delivery
BR112017009876A2 (pt) 2014-11-14 2017-12-19 Gemphire Therapeutics Inc processos e intermediários para a preparação de éteres de dialcano terminados em ácido alfa,ômega-dicarboxílico
EP3302444B1 (en) 2015-06-05 2020-09-23 Evonik Operations GmbH Pharmaceutical or nutraceutical composition with resistance against the influence of ethanol
TN2018000069A1 (en) 2015-09-01 2019-07-08 First Wave Biopharma Methods and compositions for treating conditions associated with an abnormal inflammatory responses
US10588864B2 (en) 2016-03-11 2020-03-17 Gateway Pharmaceuticals LLC Pharmaceutical compositions for colon-specific delivery
US20190111001A1 (en) * 2016-03-30 2019-04-18 University Of Maryland, Baltimore Microparticulate system for colonic drug delivery
US10076494B2 (en) 2016-06-16 2018-09-18 Dexcel Pharma Technologies Ltd. Stable orally disintegrating pharmaceutical compositions
US20190008779A1 (en) * 2017-05-11 2019-01-10 Gemphire Therapeutics Inc. Gemcabene compositions and methods of use thereof
JP7336187B2 (ja) * 2017-11-30 2023-08-31 日本ケミファ株式会社 多層構造を有する粒子状医薬組成物
WO2021115650A1 (en) 2019-12-11 2021-06-17 Evonik Operations Gmbh Dosage form for use in treating or preventing of a disease
WO2021142238A1 (en) 2020-01-10 2021-07-15 First Wave Bio, Inc. Deuterated niclosamide
US10980756B1 (en) 2020-03-16 2021-04-20 First Wave Bio, Inc. Methods of treatment
US20230190684A1 (en) 2020-03-16 2023-06-22 First Wave Bio, Inc. Methods of treating covid-19 with a niclosamide compound
CN118892464A (zh) * 2023-05-02 2024-11-05 雅典娜制药股份有限公司 美沙拉秦缓释组合物及其制备方法

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IE64726B1 (en) * 1987-11-20 1995-08-23 Elan Corp Plc Pharmaceutical formulations for preventing drug tolerance
FR2759293B1 (fr) * 1997-02-11 1999-04-30 Ethypharm Lab Prod Ethiques Microgranules contenant du cisplatine, procede de fabrication, preparation pharmaceutique et utilisation en polychimiotherapie ou en association avec une radiotherapie
DE19845358A1 (de) 1998-10-02 2000-04-06 Roehm Gmbh Überzogene Arzneiformen mit kontrollierter Wirkstoffabgabe
DE10013029A1 (de) * 2000-03-17 2001-09-20 Roehm Gmbh Mehrschichtige Arzneiform für die Colonfreigabe
DE10149674A1 (de) 2001-10-09 2003-04-24 Apogepha Arzneimittel Gmbh Orale Darreichungsformen für Propiverin oder seinen pharmazeutisch annehmbaren Salzen mit verlängerter Wirkstoffreisetzung
DE10250543A1 (de) 2002-10-29 2004-05-19 Röhm GmbH & Co. KG Mehrschichtige Arzneiform
MXPA04010956A (es) * 2003-01-30 2005-01-25 Roehm Gmbh Forma de dosis farmaceutica y metodo para la produccion de la misma.
DE10353186A1 (de) * 2003-11-13 2005-06-16 Röhm GmbH & Co. KG Mehrschichtige Arzneiform, enthaltend eine in Bezug auf die Wirkstoffabgabe modulatorisch wirkende Substanz
DE10353196A1 (de) * 2003-11-13 2005-06-16 Röhm GmbH & Co. KG Mehrschichtige Arzneiform mit einer die Abgabe einer modulatorischen Substanz beeinflussenden Matrix
GB0403098D0 (en) * 2004-02-12 2004-03-17 Euro Celtique Sa Extrusion
MX2009001597A (es) * 2006-08-18 2009-02-23 Evonik Roehm Gmbh Composicion farmaceutica con liberacion controlada de ingrediente activo para ingredientes activos con buena solubilidad en agua.
DE102007009243A1 (de) * 2007-02-22 2008-09-18 Evonik Röhm Gmbh Pellets mit einer Wirkstoff-Matrix und einem Polymerüberzug, sowie ein Verfahren zur Herstellung der Pellets
BRPI0721654B8 (pt) 2007-05-07 2022-07-05 Evonik Roehm Gmbh formas de dosagem sólida compreendendo um revestimento entérico com liberação acelerada do fármaco, seu método de fabricação e uso

Also Published As

Publication number Publication date
US9237760B2 (en) 2016-01-19
CN101877971A (zh) 2010-11-03
KR20100103566A (ko) 2010-09-27
MX2010007577A (es) 2010-08-04
US20100247639A1 (en) 2010-09-30
EP2230932A1 (en) 2010-09-29
BRPI0822026B1 (pt) 2019-05-07
EP2230932B1 (en) 2017-03-29
HUE034848T2 (en) 2018-03-28
IL205488A0 (en) 2010-12-30
KR101500792B1 (ko) 2015-03-09
IL205488A (en) 2016-08-31
BRPI0822026B8 (pt) 2021-05-25
BRPI0822026A2 (pt) 2014-10-07
PL2230932T3 (pl) 2017-09-29
JP2011509264A (ja) 2011-03-24
CA2711473A1 (en) 2009-07-16
WO2009086940A1 (en) 2009-07-16
CA2711473C (en) 2016-01-26
ES2626078T3 (es) 2017-07-21
JP5409651B2 (ja) 2014-02-05

Similar Documents

Publication Publication Date Title
SI2230932T1 (sl) Oplaščeni farmacevtski ali nutracevtski pripravek s povečanim sproščanjem aktivne učinkovine v črevesu
IL275854A (en) Pharmaceutical composition and its administration
ZA201101477B (en) Co-crystals and pharmaceutical formulations comprising the same
IL212339A (en) Pyrolobenzodiazepine derivatives and processes for their preparation
HK1158528A1 (zh) 藥物製劑
IL207128A0 (en) Pharmaceutical dosage form
IL211400A0 (en) Substituted aminoindanes and analogs thereof, and the pharmaceutical use thereof
IL209419A0 (en) Modified drugs for use in liposomal nanoparticles
ZA201104348B (en) Pharmaceutical preparation
PL2402035T3 (pl) Materiał powlekający do stałego preparatu farmaceutycznego i stały preparat farmaceutyczny utworzony z jego użyciem
HK1162936A1 (en) Solid pharmaceutical formulation with delayed release
PL394605A1 (pl) Trwała złożona kompozycja farmaceutyczna
EP2208732A4 (en) DEHYDROXYLATED VANCOMYCIN, PREPARATION THEREOF, PHARMACEUTICAL COMPOSITION AND USE THEREOF
EP2306998A4 (en) PHARMACEUTICAL FORMULATION
ZA201104710B (en) Pharmaceutical dispenser and use thereof
IL212603A0 (en) Combined drug administration
IL208788A (en) Pharmacy-based formulation
IL205492A0 (en) Coated pharmaceutical or nutraceutical preparation with accelerated controlled active substance release
IL205550A0 (en) Coated pharmaceutical or nutraceutical preparation with enhanced pulsed active substance release
EP2363132A4 (en) USE OF SOPHORICOSIDE IN DRUG MANUFACTURE
EP2309856A4 (en) PHARMACEUTICAL COMPOUNDS AS CYTOTOXICA AND ITS APPLICATION
GB0811599D0 (en) Improvements in anticancer drugs
PL381879A1 (pl) Postać preparatu farmaceutycznego oraz sposób jej otrzymywania
GB0713426D0 (en) Improvements in anticancer drugs
GB0805292D0 (en) Pharmaceutical formulation